Search and analyze individual stocks with comprehensive metrics
Windlas Biotech Limited
Fundamental Score
Windlas Biotech Limited Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of WINDLAS across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Excellent ROCE Performance (16.96%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Robust Profit Growth (31.01%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (19.95%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (18.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (30.32% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (18.11x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹78.58 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (62.34%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
2 factors identified
Weak Earnings Growth (2.83% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Windlas Biotech Limited
About WINDLAS
Company Details
Market Information
Performance
WINDLAS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of WINDLAS?
WINDLAS is currently trading at ₹912.20 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of WINDLAS shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of WINDLAS and what does it mean?
WINDLAS has a P/E ratio of 30.24x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹30 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is WINDLAS performing according to Bull Run's analysis?
WINDLAS has a Bull Run fundamental score of 71/100, which indicates strong fundamentals and excellent investment quality. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 12.76%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does WINDLAS belong to?
WINDLAS operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Windlas Biotech Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for WINDLAS?
WINDLAS has an ROE of 12.76%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Windlas Biotech Limited generates profits from shareholders' equity. An ROE of 13% means the company generates ₹13 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is WINDLAS's debt-to-equity ratio and what does it indicate?
WINDLAS has a debt-to-equity ratio of 0.06, which indicates conservative financing with low financial risk. This means the company has ₹6 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.
What is WINDLAS's dividend yield and is it a good dividend stock?
WINDLAS offers a dividend yield of 0.62%, which means you receive ₹0.62 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has WINDLAS grown over the past 5 years?
WINDLAS has achieved 5-year growth rates of: Sales Growth 18.24%, Profit Growth 30.32%, and EPS Growth 2.83%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in WINDLAS and why does it matter?
Promoters hold 62.34% of WINDLAS shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does WINDLAS compare with its industry peers?
WINDLAS trades at P/E 30.24x vs industry average 33.97x, with ROE of 12.76% and ROCE of 16.96%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether WINDLAS is outperforming its competitive set in profitability, growth, and valuation metrics.
What is WINDLAS's market capitalization and what category does it fall into?
WINDLAS has a market capitalization of ₹1971 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for WINDLAS?
Key ratios for WINDLAS: ROE 12.76% (Good), ROCE 16.96%, P/E 30.24x, Debt-to-Equity 0.06, Interest Coverage 18.11x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is WINDLAS stock and what is its beta?
WINDLAS has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for WINDLAS?
WINDLAS has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹912.20, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in WINDLAS?
Key risks for WINDLAS include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.06), and operational challenges. The stock has a Fundamental Score of 71/100, indicating strong fundamentals with lower risk profile. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is WINDLAS's operating profit margin and how has it trended?
WINDLAS has a 5-year average Operating Profit Margin (OPM) of 12.13%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is WINDLAS's quarterly performance in terms of sales and profit growth?
WINDLAS's recent quarterly performance shows YoY Sales Growth of 19.95% and YoY Profit Growth of 31.01%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in WINDLAS?
WINDLAS has FII holding of 1.44% and DII holding of 11.22%, totaling 12.66% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.